Stephen E Alway Selected Research

M-cadherin

11/2011

Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen E Alway Research Topics

Disease

9	Muscular Atrophy (Muscle Atrophy) 07/2020 - 08/2003
9	Hypertrophy 01/2012 - 01/2003
7	Atrophy 07/2020 - 04/2007
5	Sarcopenia 10/2014 - 07/2002
3	AIDS-Related Complex (ARC) 03/2009 - 07/2005
2	Inflammation (Inflammations) 01/2021 - 12/2012
2	Insulin Resistance 01/2021 - 12/2008
2	Ischemic Stroke 07/2020 - 01/2020
2	Stroke (Strokes) 07/2020 - 01/2020
2	Fatigue 01/2019 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2015 - 12/2008
2	Obesity 12/2010 - 10/2008
2	Body Weight (Weight, Body) 12/2008 - 03/2006
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Muscular Dystrophies (Muscular Dystrophy) 11/2011
1	Starvation 11/2011
1	Cachexia 01/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2008
1	Emphysema 07/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2007
1	Lacerations 02/2007
1	Fibrosis (Cirrhosis) 02/2007
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 11/2006
1	Neoplasms (Cancer) 11/2005
1	Hyperplasia 03/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2002
3	Sirtuin 1IBA 01/2021 - 01/2019
3	ResveratrolIBA 01/2014 - 07/2011
3	SuspensionsIBA 09/2011 - 03/2006
3	Messenger RNA (mRNA)IBA 07/2007 - 01/2003
2	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2005
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2018 - 11/2006
2	TeaIBA 02/2015 - 01/2014
2	Nonesterified Fatty Acids (NEFA)IBA 01/2012 - 12/2008
2	LipidsIBA 01/2012 - 10/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2003 - 01/2003
1	3,16-dihydroxyandrost-5-ene-17,19-dioneIBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	CalciumIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Muscle Proteins (Muscle Protein)IBA 01/2020
1	Particulate MatterIBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2014
1	C-Reactive ProteinIBA 12/2012
1	AntioxidantsIBA 12/2012
1	PalmitatesIBA 01/2012
1	Docosahexaenoic AcidsIBA 01/2012
1	M-cadherinIBA 11/2011
1	Leucine (L-Leucine)FDA Link 09/2011
1	PolyphenolsIBA 07/2011
1	AICA ribonucleotide (ZMP)IBA 12/2010
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2009
1	UbiquitinIBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 10/2008
1	A-factor (Streptomyces)IBA 08/2008
1	Xylazine (Xylazin)IBA 07/2007
1	Pancreatic Elastase (Elastase)IBA 07/2007
1	Ketamine FDA LinkGeneric 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007
1	Interleukin-15 (Interleukin 15)IBA 04/2007
1	CardiotoxinsIBA 02/2007
1	CytokinesIBA 02/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2007
1	Protein Isoforms (Isoforms)IBA 11/2006
1	CreatineIBA 11/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	X-Linked Inhibitor of Apoptosis ProteinIBA 08/2005
1	Inhibitor of Apoptosis ProteinsIBA 07/2005
1	CaspasesIBA 07/2005
1	Caspase 3 (Caspase-3)IBA 07/2005
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 07/2005
1	CollagenIBA 03/2004
1	Green Fluorescent ProteinsIBA 03/2004
1	Myogenic Regulatory FactorsIBA 08/2003
1	Isoflurane FDA LinkGeneric 06/2003

Therapy/Procedure

5	Denervation 01/2009 - 03/2003
2	Resistance Training 01/2011 - 10/2005
2	Anesthesia 07/2007 - 06/2003
1	Therapeutics 11/2011
1	Endurance Training 07/2005